Anticoagulant Therapy in Patients with Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by the persistent positivity of antiphospholipid antibodies (aPLA) together with thrombosis or obstetrical complications. Despite their recognized predominant role, aPLA are not sufficient to induce the development of thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Capecchi, Marco, Abbattista, Maria, Ciavarella, Alessandro, Uhr, Mario, Novembrino, Cristina, Martinelli, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741036/
https://www.ncbi.nlm.nih.gov/pubmed/36498557
http://dx.doi.org/10.3390/jcm11236984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741036/
https://www.ncbi.nlm.nih.gov/pubmed/36498557
http://dx.doi.org/10.3390/jcm11236984

Ejemplares similares